
    
      This study was terminated on June 24th, 2014 due to change in strategy of PF-03446962
      clinical development. There were no safety or efficacy concerns regarding the study behind
      the decision to terminate the trial. The study was on temporary halt since March 10th and
      there are currently no patients on treatment or in the process of being randomized
    
  